Healthcare provider profile · identity verified

Alexander D Bryan, MD

Internal Medicine · MINNEAPOLIS, MN · NPI 1184070153

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	259	55
Amlodipine Besylate	Amlodipine Besylate	137	34
Lisinopril	Lisinopril	110	29
Losartan Potassium	Losartan Potassium	98	21
Omeprazole	Omeprazole	96	21
Pantoprazole Sodium	Pantoprazole Sodium	92	20
Tamsulosin Hcl	Tamsulosin Hcl	88	19
Rosuvastatin Calcium	Rosuvastatin Calcium	86	15
Gabapentin	Gabapentin	85	22
Levothyroxine Sodium	Levothyroxine Sodium	81	13
Metformin Hcl Er	Metformin Hcl	79	17
Carvedilol	Carvedilol	78	20
Albuterol Sulfate Hfa	Albuterol Sulfate	77	20
Pregabalin	Pregabalin	68	11
Oxycodone Hcl	Oxycodone Hcl	64	suppressed
Duloxetine Hcl	Duloxetine Hcl	54	suppressed
Furosemide	Furosemide	52	14
Metoprolol Succinate	Metoprolol Succinate	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Jardiance	Empagliflozin	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	suppressed
Eliquis	Apixaban	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	15
Metformin Hcl	Metformin Hcl	35	suppressed
Finasteride	Finasteride	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Trazodone Hcl	Trazodone Hcl	34	suppressed
Ondansetron Odt	Ondansetron	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Glipizide Er	Glipizide	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	11
Potassium Chloride	Potassium Chloride	31	suppressed
Xarelto	Rivaroxaban	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Ozempic	Semaglutide	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Meloxicam	Meloxicam	25	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Lexapro	Escitalopram Oxalate	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Naproxen	Naproxen	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Latanoprost	Latanoprost	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Famotidine	Famotidine	18	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Nystatin	Nystatin	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Baclofen	Baclofen	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	13	12
Loperamide	Loperamide Hcl	13	suppressed
Prevacid	Lansoprazole	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Vesicare	Solifenacin Succinate	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error